@samfiodiving
On your point Sam of the minimum deal you would be happy with… that is the mediocre deal I was referring to.. $200m upfront. A good deal is double that and half the equity. The equity point may be the sticking point in negotiations.. you get equity if its a great deal.. I believe Roche got about 4.5% of Sarepta equity.. any more than 8% of the company is a blocking stake and can limit longer term potential upside.
See how we go.
@samfiodiving On your point Sam of the minimum deal you would be...
-
- There are more pages in this discussion • 1,654 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $89.25M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $35.68K | 354.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 196446 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 238249 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |